BU — Burcon NutraScience Share Price
- CA$28.42m
- CA$33.07m
- CA$0.36m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 10.2 | ||
Price to Tang. Book | 18.55 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 154.14 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -85.72% | ||
Return on Equity | -169.75% | ||
Operating Margin | -3754.1% |
Financial Summary
Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CA$m | 0.04 | 0.03 | 0.26 | 0.17 | 0.36 | 1.4 | 3.11 | 49.33% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Burcon NutraScience Corporation is a Canada-based technology company. The Company is engaged in the development of plant-based proteins for foods and beverages. The Company has a patent portfolio covering its specialty plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. The Company is involved in the production, sales, marketing and distribution of pulse protein ingredients, including Peazazz and Peazac pea proteins and its canola proteins, Supertein, Puratein and Nutratein (collectively, the Products). The Company's subsidiary is Burcon NutraScience (MB) Corp., which is engaged in the research and development.
Directors
- David Tyrrell NEC
- Johann Tergesen PRE
- Jade Cheng CFO
- Dorothy Law SVP (49)
- Randy Willardsen SVP
- Martin Schweizer VPR
- Alan Chan DRC
- Rosanna Chau DRC
- Debora Fang IND
- John Gilpin IND
- Peter Kappel IND
- Jeanne Mccaherty IND
- Last Annual
- March 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- November 3rd, 1998
- Public Since
- February 19th, 1999
- No. of Employees
- 18
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Toronto Stock Exchange
- Shares in Issue
- 142,088,933
- Address
- 1946 Broadway W, VANCOUVER, V6J 1Z2
- Web
- https://www.burcon.ca/
- Phone
- +1 6047330896
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for BU
Q1 2025 Burcon NutraScience Corp Earnings Release
Burcon NutraScience Corp Annual Shareholders Meeting
Similar to BU
Ceres Global Ag
Toronto Stock Exchange
Else Nutrition Holdings
Toronto Stock Exchange
GLG Life Tech
Toronto Stock Exchange
High Liner Foods
Toronto Stock Exchange
Jamieson Wellness
Toronto Stock Exchange
FAQ
As of Today at 19:04 UTC, shares in Burcon NutraScience are trading at CA$0.20. This share price information is delayed by 15 minutes.
Shares in Burcon NutraScience last closed at CA$0.20 and the price had moved by -23.08% over the past 365 days. In terms of relative price strength the Burcon NutraScience share price has underperformed the Toronto Stock Exchange 300 Composite Index by -27.01% over the past year.
The overall consensus recommendation for Burcon NutraScience is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Burcon NutraScience does not currently pay a dividend.
Burcon NutraScience does not currently pay a dividend.
Burcon NutraScience does not currently pay a dividend.
To buy shares in Burcon NutraScience you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.20, shares in Burcon NutraScience had a market capitalisation of CA$28.42m.
Here are the trading details for Burcon NutraScience:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: BU
Based on an overall assessment of its quality, value and momentum Burcon NutraScience is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Burcon NutraScience is CA$1.85. That is 825% above the last closing price of CA$0.20.
Analysts covering Burcon NutraScience currently have a consensus Earnings Per Share (EPS) forecast of -CA$0.10 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Burcon NutraScience. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +39.75%.
As of the last closing price of CA$0.20, shares in Burcon NutraScience were trading +8.99% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Burcon NutraScience PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.20.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Burcon NutraScience's management team is headed by:
- David Tyrrell - NEC
- Johann Tergesen - PRE
- Jade Cheng - CFO
- Dorothy Law - SVP
- Randy Willardsen - SVP
- Martin Schweizer - VPR
- Alan Chan - DRC
- Rosanna Chau - DRC
- Debora Fang - IND
- John Gilpin - IND
- Peter Kappel - IND
- Jeanne Mccaherty - IND